98%,内毒素<0.1EU/μg,-25~-15℃保存1年,多规格可选。" data-qmeta="description">

永利3044(中国集团)有限公司官网

分子生物学
IVD分子诊断
细胞培养与分析
蛋白研究
细胞因子
重组蛋白
抗体
高通量测序建库
病原检测UCF系列
生物医药
工具酶
抑制剂激活剂与常用试剂
仪器
耗材

PIM1 promotes hepatic conversion by suppressing reprogramming-induced ferroptosis and cell cycle arrest

Yuan Yangyang, Wang Chenwei, Zhuang Xuran, Lin Shaofeng, Luo Miaomiao, Deng Wankun, Zhou Jiaqi, Liu Lihui, Mao Lina, Peng Wenbo, Chen Jian, Wang Qiangsong, Shu Yilai, Xue Yu, Huang Pengyu

Journal:Nature Communications

IF:17.69

DOI:10.1038/s41467-022-32976-9

PMID:36068222

Published:2022-09-06

research field:生物材料生物医学工程免疫学传染病学纳米医学

Abstract

Protein kinase-mediated phosphorylation plays a critical role in many biological processes. However, the identification of key regulatory kinases is still a great challenge. Here, we develop a trans-omics-based method, central kinase inference, to predict potentially key kinases by integrating quantitative transcriptomic and phosphoproteomic data. Using known kinases associated with anti-cancer drug resistance, the accuracy of our method denoted by the area under the curve is 5.2% to 29.5% higher than Kinase-Substrate Enrichment Analysis. We further use this method to analyze trans-omic data in hepatocyte maturation and hepatic reprogramming of human dermal fibroblasts, uncovering 5 kinases as regulators in the two processes. Further experiments reveal that a serine/threonine kinase, PIM1, promotes hepatic conversion and protects human dermal fibroblasts from reprogramming-induced ferroptosis and cell cycle arrest. This study not only reveals new regulatory kinases, but also provides a helpful method that might be extended to predict central kinases involved in other biological processes.

本文使用的Yeasen产品

购物车
客服
转染试用
XML 地图